Le Lézard
Classified in: Health
Subject: SVY

Increased use of higher-cost medicines continues to put pressure on Canadian public drug plans

OTTAWA, ON, Jan. 31, 2023 /CNW/ - A new Patented Medicine Prices Review Board (PMPRB) report finds that prescription drug expenditures by Canadian public drug plans increased by 4.2% in 2020-21, bringing annual spending to $12.3 billion. The use of higher-cost medicines has been the primary factor behind rising costs for the public plans over the past five years, and this pressure continues to build.

In 2020-21, high-cost drugs accounted for over one third of total drug costs and yet were only used by 2.5% of drug plan beneficiaries. The 10 highest-cost drugs reimbursed by the public drug plans were all rare disease treatments with annual treatment costs of over $200,000.

These findings were released today by the PMPRB in the eighth edition of CompassRx, an annual report published under the National Prescription Drug Utilization Information System (NPDUIS) research initiative. CompassRx provides insight into the factors driving prescription drug expenditures in select Canadian public drug plans. This edition focuses on the 2020-21 fiscal year.

The study includes all provincial public drug plans (with the exception of Quebec), as well as Yukon and the Non-Insured Health Benefits Program. These plans account for approximately one third of the total annual spending on prescription drugs in Canada.

Quick Facts
Associated Links

CompassRx, 8th edition: Annual Public Drug Plan Expenditure Report, 2020/21

Follow us on Twitter: @PMPRB_CEPMB

SOURCE Patented Medicine Prices Review Board

These press releases may also interest you

at 14:18
A newly formalized partnership between Illinois State University and OSF HealthCare will foster research, innovation, and economic development across Illinois. The Connected Communities Initiative (CCI) program will bring together clinicians,...

at 14:15
We honour the experiences of Survivors of the Kamloops Indian Residential School and acknowledge the continued impacts on the intergenerational Survivors. Today, Kúkpi7 (Chief) Rosanne Casimir of the T?emlúps te Secwépemc, the Honourable Patty...

at 14:10
AdminaHealth®, the leading provider of premium billing solutions for the healthcare, insurance, and voluntary benefits marketplace, is proud to announce the release of the AdminaHealth Billing Suite for Carriers 2.1. This comprehensive, user-friendly...

at 14:00
Journey Biosciences, a pioneer of predictive screenings for diabetes-related complications, today announced that it has become the first company to receive a T1D Moonshot Fellowship in StartUp Health's T1D Moonshot, a bold new initiative to inspire,...

at 14:00
The "Hospital Logistics Robots Market by Type and Application - Global Opportunity Analysis and Industry Forecast 2022-2030" report has been added to  ResearchAndMarkets.com's offering. Hospital Logistics Robots Market size was valued at USD 971.25...

at 14:00
BioGX, a global provider of easy molecular diagnostic solutions, announced accelerated adoption of their high performance Sample-Ready™ PCR assay* for detection of Candida auris, a rapidly spreading, hard to treat fungus with a growing presence...

News published on 31 january 2023 at 15:00 and distributed by: